| Walmart Pharmacy 10-3638 | |
| 804 S Cashua, Florence, South Carolina 29501 | |
| (843) 269-9980 |
| Name | Walmart Pharmacy 10-3638 |
|---|---|
| Organization Name | Wal-mart Stores East Lp |
| Location | 804 S Cashua, Florence, South Carolina 29501 |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Phone | (843) 269-9980 |
| Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
A clinical trial has sifted out the most effective single-drug chemotherapy regimen for quick-growing but highly curable cancers that arise from the placentas of pregnant women.
Phase Forward, a leading provider of data management solutions for clinical trials and drug safety, today announced a multi-year agreement with PharmaNet Development Group, Inc., a global drug development services company, that enables PharmaNet to offer Phase Forward's InForm™ electronic data capture (EDC) solution to PharmaNet customers worldwide.
Medical costs this year are hitting almost everyone in the pocketbook. With politicians scrambling to come up with a workable solution, Americans face dark days ahead as monthly insurance fees go up again, often with double-digit rate hikes. Is there any hope for hard-working Americans who face the challenge of paying these exorbitant fees?
Today, the U.S. Food and Drug Administration granted accelerated approval to Jemperli (dostarlimab) for treating patients with recurrent or advanced endometrial cancer that has progressed on or following prior treatment with a platinum-containing chemotherapy and whose cancers have a specific genetic feature known as dMMR (which contain abnormalities that affect the proper repair of DNA inside the cell), as determined by an FDA-approved test.
Pfizer Inc. and Protalix BioTherapeutics, Inc. today announced the submission of a Marketing Authorization Application to the European Medicines Agency for taliglucerase alfa, a plant-cell expressed form of glucocerebrosidase (GCD)for the treatment of Gaucher disease. Taliglucerase alfa was granted Orphan Designation by the European Commission for the treatment of Gaucher disease on March 23, 2010.
› Verified 9 days ago
| NPI Number | 1497159305 |
| Organization Name | WAL-MART STORES EAST LP |
| Doing Business As | WALMART PHARMACY 10-3638 |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Address | 804 S Cashua Dr, Florence, SC 29501 |
| Phone Number | 843-269-9980 |
News Archive
A clinical trial has sifted out the most effective single-drug chemotherapy regimen for quick-growing but highly curable cancers that arise from the placentas of pregnant women.
Phase Forward, a leading provider of data management solutions for clinical trials and drug safety, today announced a multi-year agreement with PharmaNet Development Group, Inc., a global drug development services company, that enables PharmaNet to offer Phase Forward's InForm™ electronic data capture (EDC) solution to PharmaNet customers worldwide.
Medical costs this year are hitting almost everyone in the pocketbook. With politicians scrambling to come up with a workable solution, Americans face dark days ahead as monthly insurance fees go up again, often with double-digit rate hikes. Is there any hope for hard-working Americans who face the challenge of paying these exorbitant fees?
Today, the U.S. Food and Drug Administration granted accelerated approval to Jemperli (dostarlimab) for treating patients with recurrent or advanced endometrial cancer that has progressed on or following prior treatment with a platinum-containing chemotherapy and whose cancers have a specific genetic feature known as dMMR (which contain abnormalities that affect the proper repair of DNA inside the cell), as determined by an FDA-approved test.
Pfizer Inc. and Protalix BioTherapeutics, Inc. today announced the submission of a Marketing Authorization Application to the European Medicines Agency for taliglucerase alfa, a plant-cell expressed form of glucocerebrosidase (GCD)for the treatment of Gaucher disease. Taliglucerase alfa was granted Orphan Designation by the European Commission for the treatment of Gaucher disease on March 23, 2010.
› Verified 9 days ago
News Archive
A clinical trial has sifted out the most effective single-drug chemotherapy regimen for quick-growing but highly curable cancers that arise from the placentas of pregnant women.
Phase Forward, a leading provider of data management solutions for clinical trials and drug safety, today announced a multi-year agreement with PharmaNet Development Group, Inc., a global drug development services company, that enables PharmaNet to offer Phase Forward's InForm™ electronic data capture (EDC) solution to PharmaNet customers worldwide.
Medical costs this year are hitting almost everyone in the pocketbook. With politicians scrambling to come up with a workable solution, Americans face dark days ahead as monthly insurance fees go up again, often with double-digit rate hikes. Is there any hope for hard-working Americans who face the challenge of paying these exorbitant fees?
Today, the U.S. Food and Drug Administration granted accelerated approval to Jemperli (dostarlimab) for treating patients with recurrent or advanced endometrial cancer that has progressed on or following prior treatment with a platinum-containing chemotherapy and whose cancers have a specific genetic feature known as dMMR (which contain abnormalities that affect the proper repair of DNA inside the cell), as determined by an FDA-approved test.
Pfizer Inc. and Protalix BioTherapeutics, Inc. today announced the submission of a Marketing Authorization Application to the European Medicines Agency for taliglucerase alfa, a plant-cell expressed form of glucocerebrosidase (GCD)for the treatment of Gaucher disease. Taliglucerase alfa was granted Orphan Designation by the European Commission for the treatment of Gaucher disease on March 23, 2010.
› Verified 9 days ago
Apria Healthcare Llc Type: Medicare Supplier Location: 799n Cashua Dr, Florence, South Carolina 29501 Phone: (843) 665-6294 | |
Sam's Pharmacy 10-6571 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 200 N Beltline Dr, Florence, South Carolina 29501 Phone: (843) 758-6087 | |
Lincare Inc Type: Durable Medical Equipment & Medical Supplies Supplier Location: 2325 Prosperity Way, Florence, South Carolina 29501 Phone: (843) 669-7900 | |
Cvs Pharmacy #02353 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 800 Pamplico Hwy, Florence, South Carolina 29505 Phone: (843) 292-0621 | |
Cvs Pharmacy #05470 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 3210 E Palmetto Street, Florence, South Carolina 29506 Phone: (843) 662-3740 |